10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended April 2, 2022

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 000-25121

_______________________________________________________________________

SLEEP NUMBER CORPORATION

(Exact name of registrant as specified in its charter)

Minnesota	41-1597886
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

1001 Third Avenue South
Minneapolis,	Minnesota	55404
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (763) 551-7000

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	SNBR	Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ☐ No ☒

As of April 2, 2022, 22,232,000 shares of the registrant’s Common Stock were outstanding.

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

INDEX

		Page
PART I: FINANCIAL INFORMATION		1
Item 1.	Financial Statements (unaudited)	1
	Condensed Consolidated Balance Sheets	1
	Condensed Consolidated Statements of Operations	2
	Condensed Consolidated Statements of Shareholders' Deficit	3
	Condensed Consolidated Statements of Cash Flows	4
	Notes to Condensed Consolidated Financial Statements	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	12
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	22
Item 4.	Controls and Procedures	22
PART II: OTHER INFORMATION		23
Item 1.	Legal Proceedings	23
Item 1A.	Risk Factors	23
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	23
Item 3.	Defaults Upon Senior Securities	23
Item 4.	Mine Safety Disclosures	23
Item 5.	Other Information	23
Item 6.	Exhibits	24
SIGNATURES		25

i | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

PART I: FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(unaudited - in thousands, except per share amounts)

	April 2, 2022		January 1, 2022
Assets
Current assets:
Cash and cash equivalents	$	1,556	$	2,389
Accounts receivable, net of allowances of $1,047 and $924, respectively	24,502		25,718
Inventories	103,212		105,644
Prepaid expenses	22,001		18,953
Other current assets	40,624		54,917
Total current assets	191,895		207,621
Non-current assets:
Property and equipment, net	197,644		195,128
Operating lease right-of-use assets	374,650		371,133
Goodwill and intangible assets, net	69,867		70,468
Other non-current assets	78,529		75,190
Total assets	$	912,585	$	919,540
Liabilities and Shareholders’ Deficit
Current liabilities:
Borrowings under revolving credit facility	$	413,200	$	382,500
Accounts payable	177,025		162,547
Customer prepayments	142,005		129,499
Accrued sales returns	20,277		22,368
Compensation and benefits	25,702		51,240
Taxes and withholding	26,293		22,087
Operating lease liabilities	74,046		72,360
Other current liabilities	59,390		64,177
Total current liabilities	937,938		906,778
Non-current liabilities:
Deferred income taxes	312		688
Operating lease liabilities	338,528		336,192
Other non-current liabilities	105,020		100,835
Total liabilities	1,381,798		1,344,493
Shareholders’ deficit:
Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding	—		—
Common stock, $0.01 par value; 142,500 shares authorized, 22,232 and 22,683 shares issued and outstanding, respectively	222		227
Additional paid-in capital	—		3,971
Accumulated deficit	(469,435)		(429,151)
Total shareholders’ deficit	(469,213)		(424,953)
Total liabilities and shareholders’ deficit	$	912,585	$	919,540

See accompanying notes to condensed consolidated financial statements.

1 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(unaudited - in thousands, except per share amounts)

	Three Months Ended
	April 2, 2022		April 3, 2021
Net sales	$	527,130	$	568,256
Cost of sales	224,832		212,338
Gross profit	302,298		355,918
Operating expenses:
Sales and marketing	240,259		223,617
General and administrative	41,319		42,592
Research and development	16,305		13,286
Total operating expenses	297,883		279,495
Operating income	4,415		76,423
Interest expense, net	2,127		977
Income before income taxes	2,288		75,446
Income tax expense	214		8,812
Net income	$	2,074	$	66,634
Basic net income per share:
Net income per share – basic	$	0.09	$	2.63
Weighted-average shares – basic	22,760		25,377
Diluted net income per share:
Net income per share – diluted	$	0.09	$	2.51
Weighted-average shares – diluted	23,591		26,544

See accompanying notes to condensed consolidated financial statements.

2 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Condensed Consolidated Statements of Shareholders’ Deficit

(unaudited - in thousands)

	Common Stock			Additional Paid-in Capital		Accumulated Deficit		Total
	Shares	Amount
Balance at January 1, 2022	22,683	$	227	$	3,971	$	(429,151)	$	(424,953)
Net income	—	—		—		2,074		2,074
Exercise of common stock options	21	—		531		—		531
Stock-based compensation	341	3		4,130		—		4,133
Repurchases of common stock	(813)	(8)		(8,632)		(42,358)		(50,998)
Balance at April 2, 2022	22,232	$	222	$	—	$	(469,435)	$	(469,213)

	Common Stock			Additional Paid-in Capital		Accumulated Deficit		Total
	Shares	Amount
Balance at January 2, 2021	25,390	$	254	$	—	$	(224,232)	$	(223,978)
Net income	—	—		—		66,634		66,634
Exercise of common stock options	106	1		2,459		—		2,460
Stock-based compensation	314	3		6,413		—		6,416
Repurchases of common stock	(1,346)	(13)		(8,872)		(175,297)		(184,182)
Balance at April 3, 2021	24,464	$	245	$	—	$	(332,895)	$	(332,650)

See accompanying notes to condensed consolidated financial statements.

3 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(unaudited - in thousands)

	Three Months Ended
	April 2, 2022		April 3, 2021
Cash flows from operating activities:
Net income	$	2,074	$	66,634
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	15,870		14,638
Stock-based compensation	4,133		6,416
Net loss on disposals and impairments of assets	93		78
Deferred income taxes	(376)		1,515
Changes in operating assets and liabilities:
Accounts receivable	1,216		5,948
Inventories	2,432		(946)
Income taxes	1,102		6,847
Prepaid expenses and other assets	10,877		(3,113)
Accounts payable	2,073		12,390
Customer prepayments	12,506		20,552
Accrued compensation and benefits	(25,348)		(34,605)
Other taxes and withholding	3,104		8,912
Other accruals and liabilities	(5,198)		6,332
Net cash provided by operating activities	24,558		111,598
Cash flows from investing activities:
Purchases of property and equipment	(19,604)		(11,546)
Proceeds from sales of property and equipment	10		12
Net cash used in investing activities	(19,594)		(11,534)
Cash flows from financing activities:
Repurchases of common stock	(50,998)		(178,613)
Net increase in short-term borrowings	44,712		74,087
Proceeds from issuance of common stock	531		2,460
Debt issuance costs	(42)		(3)
Net cash used in financing activities	(5,797)		(102,069)
Net decrease in cash and cash equivalents	(833)		(2,005)
Cash and cash equivalents, at beginning of period	2,389		4,243
Cash and cash equivalents, at end of period	$	1,556	$	2,238

See accompanying notes to condensed consolidated financial statements.

4 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(unaudited)

1. Business and Summary of Significant Accounting Policies

Business & Basis of Presentation

We prepared the condensed consolidated financial statements as of and for the three months ended April 2, 2022 of Sleep Number Corporation and our 100%-owned subsidiaries (Sleep Number or the Company), without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) and they reflect, in the opinion of management, all normal recurring adjustments necessary to present fairly our financial position as of April 2, 2022 and January 1, 2022, and the consolidated results of operations and cash flows for the periods presented. Our historical and quarterly consolidated results of operations may not be indicative of the results that may be achieved for the full year or any future period. In addition, based on the duration and severity of the current global situation involving the COVID-19 pandemic, the war in Ukraine and other external factors, including but not limited to general economic conditions, inflation, consumer confidence, store restrictions mandated by federal, state or local authorities and global supply chain disruptions, the extent to which these external factors will impact our business and our consolidated financial results will depend on future developments, which are highly uncertain and cannot be predicted.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP) have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements should be read in conjunction with our most recent audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended January 1, 2022 and other recent filings with the SEC.

The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of sales, expenses and income taxes during the reporting period. Predicting future events is inherently an imprecise activity and, as such, requires the use of judgment. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. In addition, during the current environment involving external factors such as COVID-19 and the war in Ukraine, predicting future events will be especially challenging for management. Changes in these estimates will be reflected in the consolidated financial statements in future periods and could be material. Our critical accounting policies consist of stock-based compensation, warranty liabilities and revenue recognition.

The condensed consolidated financial statements include the accounts of Sleep Number Corporation and our 100%-owned subsidiaries. All significant intra-entity balances and transactions have been eliminated in consolidation.

2. Fair Value Measurements

At April 2, 2022 and January 1, 2022, we had $18 million and $19 million, respectively, of debt and equity securities that fund our deferred compensation plan and are classified in other non-current assets. We also had corresponding deferred compensation plan liabilities of $18 million and $19 million at April 2, 2022 and January 1, 2022, respectively, which are included in other non-current liabilities. The majority of the debt and equity securities are Level 1 as they trade with sufficient frequency and volume to enable us to obtain pricing information on an ongoing basis. Unrealized gains/(losses) on the debt and equity securities offset those associated with the corresponding deferred compensation plan liabilities.

5 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(unaudited)

3. Inventories

Inventories consisted of the following (in thousands):

	April 2, 2022		January 1, 2022
Raw materials	$	11,257	$	11,752
Work in progress	68		83
Finished goods	91,887		93,809
	$	103,212	$	105,644

4. Goodwill and Intangible Assets, Net

Goodwill and Indefinite-lived Intangible Assets

Goodwill was $64 million at April 2, 2022 and January 1, 2022. Indefinite-lived trade name/trademarks totaled $1.4 million at April 2, 2022 and January 1, 2022.

Definite-lived Intangible Assets

The gross carrying amount of our developed technologies was $19 million at April 2, 2022 and January 1, 2022. Accumulated amortization was $16 million at April 2, 2022 and January 1, 2022. Amortization expense for both the three months ended April 2, 2022 and April 3, 2021, was $0.5 million.

The gross carrying amount of our patents was $2 million at April 2, 2022 and January 1, 2022. Accumulated amortization was $0.4 million and $0.3 million at April 2, 2022 and January 1, 2022, respectively. Amortization expense for both the three months ended April 2, 2022 and April 3, 2021, was $55 thousand.

Annual amortization for definite-lived intangible assets for subsequent years are as follows (in thousands):

2022 (excluding the three months ended April 2, 2022)	$	1,802
2023	1,431
2024	222
2025	226
2026	222
2027	222
Thereafter	300
Total future amortization for definite-lived intangible assets	$	4,425

5. Credit Agreement

As of April 2, 2022, our credit facility had a total commitment amount of $825 million. The credit facility is for general corporate purposes, to meet our seasonal working capital requirements and to repurchase our stock. The credit agreement includes an accordion feature which allows us to increase the amount of the credit facility from $825 million to $1.2 billion, subject to lenders’ approval. The credit agreement provides the lenders with a collateral security interest in substantially all of our assets and those of our subsidiaries and requires us to comply with, among other things, a maximum leverage ratio (4.5x) and a minimum interest coverage ratio (3.0x). Under the terms of the credit agreement, we pay a variable rate of interest and a commitment fee based on our leverage ratio. The credit agreement matures in December 2026. We were in compliance with all financial covenants as of April 2, 2022.

6 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(unaudited)

The following table summarizes our borrowings under the credit facility ($ in thousands):

	April 2, 2022			January 1, 2022
Outstanding borrowings	$	413,200		$	382,500
Outstanding letters of credit	$	5,947		$	3,997
Additional borrowing capacity	$	405,853		$	438,503
Weighted-average interest rate	2.2		%	1.6		%

6. Leases

We lease our retail, office and manufacturing space under operating leases which, in addition to the minimum lease payments, may require payment of a proportionate share of the real estate taxes and certain building operating expenses. While our local market development approach generally results in long-term participation in given markets, our retail store leases generally provide for an initial lease term of five to 10 years. Our office and manufacturing leases provide for an initial lease term of up to 15 years. In addition, our mall-based retail store leases may require payment of variable rent based on net sales in excess of certain thresholds. Certain leases may contain options to extend the term of the original lease. The exercise of lease renewal options is at our sole discretion. Lease options are included in the lease term only if exercise is reasonably certain at lease commencement. Our lease agreements do not contain any material residual value guarantees. We also lease vehicles and certain equipment under operating leases with an initial lease term of three to five years.

Our operating lease costs include facility, vehicle and equipment lease costs, but exclude variable lease costs. Operating lease costs are recognized on a straight-line basis over the lease term, after consideration of rent escalations and rent holidays. The lease term for purposes of the calculation begins on the earlier of the lease commencement date or the date we take possession of the property. During lease renewal negotiations that extend beyond the original lease term, we estimate straight-line rent expense based on current market conditions. Variable lease costs are recorded when it is probable the cost has been incurred and the amount can be reasonably estimated. Future payments for real estate taxes and certain building operating expenses for which we are obligated are not included in operating lease costs.

At April 2, 2022, our finance right-of-use assets and lease liabilities were not significant.

Lease costs were as follows (in thousands):

	Three Months Ended
	April 2, 2022		April 3, 2021
Operating lease costs(1)	$	27,078	$	23,638
Variable lease costs	$	330	$	515

___________________________

(1)Includes short-term lease costs which are not significant.

7 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(unaudited)

The maturities of operating lease liabilities as of April 2, 2022, were as follows(1) (in thousands):

2022 (excluding the three months ended April 2, 2022)	$	72,962
2023	89,790
2024	77,978
2025	68,001
2026	56,694
2027	41,517
Thereafter	86,958
Total operating lease payments(2)	493,900
Less: Interest	81,326
Present value of operating lease liabilities	$	412,574

___________________________

(1)Total operating lease payments exclude $102 million of legally binding minimum lease payments for leases signed but not yet commenced.

(2)Includes the current portion of $74 million for operating lease liabilities.

Other information related to operating leases was as follows:

	April 2, 2022		January 1, 2022
Weighted-average remaining lease term (years)	6.3		6.4
Weighted-average discount rate	6.0	%	6.1	%

	Three Months Ended
(in thousands)	April 2, 2022		April 3, 2021
Cash paid for amounts included in present value of operating lease liabilities	$	24,209	$	21,386
Right-of-use assets obtained in exchange for operating lease liabilities	$	17,564	$	29,454

7. Repurchases of Common Stock

Repurchases of our common stock were as follows (in thousands):

	Three Months Ended
	April 2, 2022		April 3, 2021
Amount repurchased under Board-approved share repurchase program	$	42,308	$	167,418
Amount repurchased in connection with the vesting of employee restricted stock grants	8,690		16,764
Total amount repurchased (based on trade dates)	$	50,998	$	184,182

As of April 2, 2022, the remaining authorization under the $600 million share repurchase program was $361 million.

8 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(unaudited)

8. Revenue Recognition

Deferred contract assets and deferred contract liabilities are included in our condensed consolidated balance sheets as follows (in thousands):

	April 2, 2022		January 1, 2022
Deferred contract assets included in:
Other current assets	$	26,926	$	28,048
Other non-current assets	53,244		49,343
	$	80,170	$	77,391

	April 2, 2022		January 1, 2022
Deferred contract liabilities included in:
Other current liabilities	$	34,999	$	36,490
Other non-current liabilities	68,657		63,680
	$	103,656	$	100,170

The deferred revenue and costs related to SleepIQ® technology are currently recognized on a straight-line basis over the product's estimated life of 4.5 to 5.0 years because our inputs are generally expended evenly throughout the performance period. During the three months ended April 2, 2022 and April 3, 2021, we recognized revenue of $9 million and $7 million, respectively, that were included in the deferred contract liability balances at the beginning of the respective periods.

Revenue from goods and services transferred to customers at a point in time accounted for approximately 98% of our revenues for the three months ended April 2, 2022 and 99% of our revenues for the three months ended April 3, 2021.

Net sales were as follows (in thousands):

	Three Months Ended
	April 2, 2022		April 3, 2021
Retail stores	$	444,336	$	489,188
Online, phone, chat and other	82,794		79,068
Total Company	$	527,130	$	568,256

Obligation for Sales Returns

The activity in the sales returns liability account was as follows (in thousands):

	Three Months Ended
	April 2, 2022		April 3, 2021
Balance at beginning of year	$	22,368	$	24,765
Additions that reduce net sales	26,667		23,711
Deductions from reserves	(28,758)		(23,866)
Balance at end of period	$	20,277	$	24,610

9 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(unaudited)

9. Stock-based Compensation Expense

Total stock-based compensation expense was as follows (in thousands):

	Three Months Ended
	April 2, 2022		April 3, 2021
Stock awards	$	3,274	$	5,808
Stock options	859		608
Total stock-based compensation expense (1)	4,133		6,416
Income tax benefit	1,033		1,598
Total stock-based compensation expense, net of tax	$	3,100	$	4,818

___________________________

(1) Changes in stock-based compensation expense reflect the cumulative impact of the change in the expected achievements of certain performance targets.

10. Profit Sharing and 401(k) Plan

Under our profit sharing and 401(k) plan, eligible employees may defer up to 50% of their compensation on a pre-tax basis, subject to Internal Revenue Service limitations. Each pay period, we may make a discretionary contribution equal to a percentage of the employee’s contribution. During the three months ended April 2, 2022 and April 3, 2021, our contributions, net of forfeitures, were $2.8 million and $1.9 million, respectively.

11. Net Income per Common Share

The components of basic and diluted net income per share were as follows (in thousands, except per share amounts):

	Three Months Ended
	April 2, 2022		April 3, 2021
Net income	$	2,074	$	66,634
Reconciliation of weighted-average shares outstanding:
Basic weighted-average shares outstanding	22,760		25,377
Dilutive effect of stock-based awards	831		1,167
Diluted weighted-average shares outstanding	23,591		26,544
Net income per share – basic	$	0.09	$	2.63
Net income per share – diluted	$	0.09	$	2.51

For the three months ended April 2, 2022 and April 3, 2021, anti-dilutive stock-based awards excluded from the diluted net income per share calculations were immaterial.

10 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(unaudited)

12. Commitments and Contingencies

Warranty Liabilities

The activity in the accrued warranty liabilities account was as follows (in thousands):

	Three Months Ended
	April 2, 2022		April 3, 2021
Balance at beginning of year	$	10,069	$	12,152
Additions charged to costs and expenses for current-year sales	4,447		4,330
Deductions from reserves	(4,750)		(4,717)
Changes in liability for pre-existing warranties during the current year, including expirations	(31)		(156)
Balance at end of period	$	9,735	$	11,609

Legal Proceedings

We are involved from time to time in various legal proceedings arising in the ordinary course of our business, including primarily commercial, product liability, employment and intellectual property claims. In accordance with U.S. generally accepted accounting principles, we record a liability in our consolidated financial statements with respect to any of these matters when it is both probable that a liability has been incurred and the amount of the liability can be reasonably estimated. If a material loss is reasonably possible but not known or probable, and may be reasonably estimated, the estimated loss or range of loss is disclosed. With respect to currently pending legal proceedings, we have not established an estimated range of reasonably possible material losses either because we believe that we have valid defenses to claims asserted against us, the proceeding has not advanced to a stage of discovery that would enable us to establish an estimate, or the potential loss is not material. We currently do not expect the outcome of pending legal proceedings to have a material effect on our consolidated results of operations, financial position or cash flows. Litigation, however, is inherently unpredictable, and it is possible that the ultimate outcome of one or more claims asserted against us could adversely impact our consolidated results of operations, financial position or cash flows. We expense legal costs as incurred.

On December 14, 2021, Steamfitters Local 449 Pension & Retirement Security Funds filed a putative class action complaint in the United States District Court for the District of Minnesota on behalf of all purchasers of Sleep Number common stock between February 18, 2021 and July 20, 2021, inclusive, against Sleep Number, Shelly Ibach and David Callen. Plaintiff alleges material misstatements and omissions in certain of Sleep Number’s public disclosures during the purported class period, in violation of Section 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended. The complaint seeks, among other things, unspecified monetary damages, reasonable costs and expenses and equitable/injunctive or other relief as deemed appropriate by the Court. We believe these claims are without merit and intend to vigorously defend the matter.

13. COVID-19 Pandemic

The COVID-19 pandemic impacted our 2021 and 2022 financial performance. In the first quarter of 2021, even with the COVID-19 challenges, we generated strong demand and financial performance. In the first quarter of 2022, our financial performance was impacted by: (i) the disruptive flow of semiconductor chips which affected our ability to deliver products to our customers and suppressed consumer confidence; (ii) incremental costs from labor and material inflation, and expediting costs resulting from current-period global supply chain shortages; and (iii) increased investments in our long- and near-term innovations and demand drivers, partly offset by cost containment actions. The pandemic's future effects on our global supply chain and the potential for supply disruption (e.g., the lack or slowing of critical components caused by labor shortages or government-mandated work closures), effects on consumer demand and effects on our ongoing financial performance remains uncertain. See Part II, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations and Part II: Item 1A. Risk Factors for additional discussion on the COVID-19 pandemic and the impact on our business.

11 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is intended to provide a reader of our condensed consolidated financial statements with a narrative from the perspective of management on our financial condition, results of operations, liquidity and certain other factors that may affect our future results. Our MD&A is presented in eight sections:

•Forward-Looking Statements and Risk Factors

•Business Overview

•COVID-19 Pandemic - Impact on our Business

•Results of Operations

•Liquidity and Capital Resources

•Non-GAAP Data Reconciliations

•Off-Balance-Sheet Arrangements and Contractual Obligations

•Critical Accounting Policies

Forward-looking Statements and Risk Factors

The discussion in this Quarterly Report contains certain forward-looking statements that relate to future plans, events, financial results or performance. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “will,” “should,” “could,” “expect,” “anticipate,” “believe,” “estimate,” “plan,” “project,” “predict,” “intend,” “potential,” “continue” or the negative of these or similar terms. These statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, among others:

•Current and future general and industry economic trends and consumer confidence;

•Risks inherent in outbreaks of pandemics or contagious disease, including the COVID-19 pandemic;

•Risks inherent in global-sourcing activities, including tariffs, outbreaks of pandemics or contagious diseases, such as the COVID-19 pandemic, geo-political turmoil, acts of terrorism, global conflicts or war (such as the current war in Ukraine), strikes, labor shortages, government-mandated work closures, and the potential for shortages in supply or disruption or delay of production and delivery of materials and products in our global supply chain;

•Risks of disruption in the operation of any of our main manufacturing, distribution, logistics, home delivery, product development, or customer service facilities or operations;

•Our manufacturing processes operate with minimal levels of inventory, which may leave us vulnerable to shortages in supply;

•Our dependence on significant suppliers and third parties and our ability to maintain relationships with key suppliers or third parties, including several sole-source suppliers or service providers;

•Rising commodity costs and other inflationary pressures;

•The effectiveness of our marketing messages;

•The efficiency of our advertising and promotional efforts;

•Our ability to execute our Total Retail distribution strategy;

•Our ability to achieve and maintain acceptable levels of product and service quality, and acceptable product return and warranty claims rates;

•Our ability to continue to improve and expand our product line, and consumer acceptance of our products, product quality, innovation and brand image;

•Industry competition, the emergence of additional competitive products and the adequacy of our intellectual-property rights to protect our products and brand from competitive or infringing activities;

•Claims that our products, processes, advertising or trademarks infringe the intellectual-property rights of others;

•Availability of attractive and cost-effective consumer credit options;

•Increasing government regulation;

•Pending or unforeseen litigation and the potential for adverse publicity associated with litigation;

12 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

•The adequacy of our and third-party information systems to meet the evolving needs of our business and existing and evolving risks and regulatory standards applicable to data privacy and cybersecurity;

•The costs and potential disruptions to our business related to upgrading or maintaining our information systems;

•The vulnerability of our and third-party information systems to attacks by hackers or other cyber threats that could compromise the security of our systems, result in a data breach or disrupt our business;

•Environmental risks, including increasing environmental regulation and the broader impacts of climate change such as from weather-related events; and

•Our ability, and the ability of our suppliers and vendors, to attract, retain and motivate qualified management, executive and other key team members, including qualified retail sales professionals and managers.

Additional information concerning these, and other risks and uncertainties is contained under the caption “Risk Factors” below in Part II: Item 1A of this Quarterly Report on Form 10-Q and under the same caption in our Annual Report on Form 10-K.

We have no obligation to publicly update or revise any of the forward-looking statements contained in this Quarterly Report on Form 10-Q.

Business Overview

At Sleep Number, our purpose is to improve the health and wellbeing of society through higher quality sleep. We are

committed to leveraging the power of sleep, and sleep science, to improve lives and create a healthier, kinder, more

inclusive world. And because our more than 5,500 team members are dedicated to our mission as well as the disciplined

execution of our vertically integrated business model and differentiated strategy, Sleep Number is at the forefront of

sleep innovation. As the exclusive designer, manufacturer, marketer, retailer and servicer of Sleep Number 360 smart

beds and SleepIQ® technology, Sleep Number is uniquely equipped to offer the life-changing benefit of high-quality,

individualized sleep solutions and services. To date, we have improved over 14 million lives.

With our enterprise-wide investments in innovation, technology, logistics, marketing and customer service, Sleep

Number has created a highly relevant, competitively advantaged strategy and has become a beloved brand built on a

foundation of individuality and wellbeing. Together with our expertise in sleep research, commitment to data science

and analytics, and deep understanding of consumers – including structural shifts in their behavior that we have

anticipated since the 2012 inception of our consumer innovation strategy and which were accelerated by the global

pandemic – we are driving profitable growth and delivering superior value for all our stakeholders.

We generate revenue by marketing our innovations directly to new and existing customers, and selling products through our Stores, Online, Phone, Chat (Total Retail) and Other.

We are committed to delivering superior shareholder value by: (1) increasing consumer demand; (2) leveraging our business model; and (3) deploying capital efficiently.

COVID-19 Pandemic - Impact on our Business

The COVID-19 pandemic impacted our 2021 and 2022 financial performance. In the first quarter of 2021, even with the COVID-19 challenges, we generated strong demand and financial performance. In the first quarter of 2022, our financial performance was impacted by: (i) the disruptive flow of semiconductor chips which affected our ability to deliver products to our customers and suppressed consumer confidence; (ii) incremental costs from labor and material inflation, and expediting costs resulting from current-period global supply chain shortages; and (iii) increased investments in our long- and near-term innovations and demand drivers, partly offset by cost containment actions. The pandemic's future effects on our global supply chain and the potential for supply disruption (e.g., the lack or slowing of critical components caused by labor shortages or government-mandated work closures), effects on consumer demand and effects on our ongoing financial performance remains uncertain. See Part II, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations and Part II: Item 1A. Risk Factors for additional discussion on the COVID-19 pandemic and the impact on our business.

13 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

Results of Operations

Quarterly and Year-to-Date Results

Quarterly and year-to-date operating results may fluctuate significantly as a result of a variety of factors, including increases or decreases in sales, timing, amount and effectiveness of advertising expenditures, changes in sales return rates or warranty experience, timing of investments in growth initiatives and infrastructure, timing of store openings/closings and related expenses, changes in net sales resulting from changes in our store base, timing of new product introductions and related expenses, timing of promotional offerings, competitive factors, changes in commodity costs, disruptions in global supplies or third-party service providers, seasonality of retail and bedding industry sales, consumer confidence and general economic conditions. In addition, based on the duration and severity of the current global situation involving the COVID-19 pandemic, the war in Ukraine and other external factors, including but not limited to general economic conditions, inflation, consumer confidence, store restrictions mandated by federal, state or local authorities and global supply chain disruptions, the extent to which these external factors will impact our business and our consolidated financial results will depend on future developments, which are highly uncertain and cannot be predicted. Therefore, our historical results of operations may not be indicative of the results that may be achieved for any future period.

Highlights

Financial highlights for the three months ended April 2, 2022 were as follows:

•Net sales for the three months ended April 2, 2022 decreased 7% to $527 million, compared with $568 million for the three months ended April 3, 2021. Demand was negatively impacted by acute macro factors including the COVID-19 variant in January and the war in Ukraine in March. Global supply constraints continued to impact our delivered net sales for the three months ended April 2, 2022.

•The 7% net sales decrease consisted of an 11% comparable sales decline in Total Retail offset by sales from 46 net new stores opened in the past 12 months that added 4 percentage points (ppt.) of growth. For additional details, see the components of total net sales change on page 15.

•Sales per store (sales for stores open at least one year, Total Retail, including online, phone and chat) on a trailing twelve-month basis for the period ended April 2, 2022 totaled $3.5 million, 9% higher than the same period last year.

•Operating income for the three months ended April 2, 2022 was $4 million, compared with $76 million in the prior-year period. The $72 million decrease in operating income was driven by the 7% decrease in net sales constrained by semiconductor chip supply, a 7.3 ppt. increase in our operating expenses rate, and a 5.3 ppt. decrease in our gross profit rate that was negatively affected by cost pressures and an unfavorable mix of smart bed deliveries as constrained by semiconductor chip supply.

•The 5.3 ppt. gross profit rate decrease was primarily due to incremental costs from labor and material inflation, and inefficiencies resulting from current-period global supply chain shortages, in addition to the deleveraging impact of the 7% net sales decline and a less favorable sales mix of lower-margin products. See the Gross profit discussion on page 17 for additional details.

•The 7.3 ppt. increase in our operating expenses rate was partially due to the deleveraging impact of the 7% net sales decline. In addition, we continued to prioritize investments in near- and long-term growth drivers, including $16 million of R&D expenses during the three months ended April 2, 2022, 23% more than the same period one year ago.

•Net income for the three months ended April 2, 2022 decreased to $2 million, compared with $67 million for the same period one year ago. Net income per diluted share was $0.09, compared with $2.51 last year.

•We achieved a return on invested capital (ROIC) of 20.5% on a trailing twelve-month basis for the period ended April 2, 2022, compared with 27.6% for the comparable period one year ago.

•Cash provided by operating activities for the three months ended April 2, 2022 decreased to $25 million, compared with $112 million for the same period one year ago.

•As of April 2, 2022, we had $413 million of borrowings under our revolving credit facility and available net liquidity of $406 million.

14 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

The following table sets forth our results of operations expressed as dollars and percentages of net sales. Figures are in millions, except percentages and per share amounts. Amounts may not add due to rounding differences.

	Three Months Ended
	April 2, 2022				April 3, 2021
Net sales	$	527.1	100.0	%	$	568.3	100.0	%
Cost of sales	224.8		42.7	%	212.3		37.4	%
Gross profit	302.3		57.3	%	355.9		62.6	%
Operating expenses:
Sales and marketing	240.3		45.6	%	223.6		39.4	%
General and administrative	41.3		7.8	%	42.6		7.5	%
Research and development	16.3		3.1	%	13.3		2.3	%
Total operating expenses	297.9		56.5	%	279.5		49.2	%
Operating income	4.4		0.8	%	76.4		13.4	%
Interest expense, net	2.1		0.4	%	1.0		0.2	%
Income before income taxes	2.3		0.4	%	75.4		13.3	%
Income tax expense	0.2		—	%	8.8		1.6	%
Net income	$	2.1	0.4	%	$	66.6	11.7	%
Net income per share:
Basic	$	0.09			$	2.63
Diluted	$	0.09			$	2.51
Weighted-average number of common shares:
Basic	22.8				25.4
Diluted	23.6				26.5

The percentage of our total net sales, by dollar volume, was as follows:

	Three Months Ended
	April 2, 2022		April 3, 2021
Retail stores	84.3	%	86.1	%
Online, phone, chat and other	15.7	%	13.9	%
Total Company	100.0	%	100.0	%

The components of total net sales change, including comparable net sales changes, were as follows:

	Three Months Ended
	April 2, 2022		April 3, 2021
Sales change rates:
Retail comparable-store sales (1)	(14	%)	12	%
Online, phone and chat	5	%	116	%
Total Retail comparable sales change (1)	(11	%)	20	%
Net opened/closed stores and other	4	%	—	%
Total Company	(7	%)	20	%

___________________________

(1)Stores are included in the comparable-store calculations in the 13th full month of operations. Stores that have been remodeled or repositioned within the same shopping center remain in the comparable-store base.

15 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

Other sales metrics were as follows:

	Three Months Ended
	April 2, 2022			April 3, 2021
Average sales per store (1) (in thousands)	$	3,487		$	3,196
Average sales per square foot (1)	$	1,167		$	1,095
Stores > $2 million in net sales (2)	82		%	71		%
Stores > $3 million in net sales (2)	46		%	33		%
Average revenue per smart bed unit (3)	$	4,905		$	5,030

___________________________

(1)Trailing-twelve months Total Retail comparable sales per store open at least one year.

(2)Trailing-twelve months for stores open at least one year (excludes online, phone and chat sales).

(3)Represents Total Retail net sales divided by Total Retail smart bed units.

The number of retail stores operating was as follows:

	Three Months Ended
	April 2, 2022	April 3, 2021
Beginning of period	648	602
Opened	13	11
Closed	(8)	(6)
End of period	653	607

16 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

Comparison of Three Months Ended April 2, 2022 with Three Months Ended April 3, 2021

Net sales

Net sales for the three months ended April 2, 2022 decreased by $41 million, or 7%, to $527 million, compared with $568 million for the same period one year ago. Demand was negatively impacted by acute macro factors including the COVID-19 variant in January and war in Ukraine in March. Global supply constraints negatively impacted our delivered net sales for the three months ended April 2, 2022.

The 7% net sales decrease consisted primarily of an 11% comparable sales decline in Total Retail offset by sales from 46 net new stores opened in the past 12 months that added 4 percentage points (ppt.) of growth. For additional details, see the components of total net sales change on page 15.

The $41 million net sales decline compared with the same period one year ago was comprised of the following: (i) a $59 million decrease in our Total Retail comparable net sales; and (ii) an $18 million increase from net store openings. Total Retail smart bed unit sales decreased 5% compared with the prior year. Total Retail average revenue per smart bed unit decreased by 2% to $4,905, compared with $5,030 in the prior-year period and was negatively impacted by a less favorable sales mix due to supply constraints impacting smart bed deliveries at the higher end of our product line.

Gross profit

Gross profit of $302 million for the three months ended April 2, 2022 decreased by $54 million, or 15%, compared with $356 million for the same period one year ago. The gross profit rate declined to 57.3% of net sales for the three months ended April 2, 2022, compared with 62.6% for the prior-year comparable period.

The current-year gross profit rate decrease of 5.3 ppt. was mainly due to: (i) incremental costs from labor and material inflation and inefficiencies resulting from current-period global supply chain shortages (4.2 ppt.); (ii) the deleverage from the 7% net sales decrease; and (iii) a less favorable sales mix of lower-margin products due to supply constraints impacting smart bed deliveries at the higher end of our product line. These pressures were partially offset by pricing actions taken over the past twelve months (1.7 ppt.). In addition, our gross profit rate will fluctuate from quarter to quarter due to a variety of other factors, including return and exchange costs, and changes in performance-based incentive compensation.

Sales and marketing expenses

Sales and marketing expenses for the three months ended April 2, 2022 were $240 million, or 45.6% of net sales, compared with $224 million, or 39.4% of net sales, for the same period one year ago. The current-year sales and marketing expenses rate increase of 6.2 ppt. was primarily due to: (i) the deleveraging impact of the 7% net sales decrease as constrained by semiconductor chip supply; (ii) addition of 46 net new stores; and (iii) increased marketing expenses resulting from a 9% increase in media expenses.

General and administrative expenses

General and administrative (G&A) expenses totaled $41 million, or 7.8% of net sales, for the three months ended April 2, 2022, compared with $43 million, or 7.5% of net sales, in the prior-year period. The $1.3 million decrease in G&A expenses consisted mainly of: (i) a $6.7 million decrease in employee compensation primarily resulting from a year-over-year decrease in Company-wide performance-based incentive compensation; offset by (ii) a $5.4 million increase in other miscellaneous expenses, including technology investments and travel expenses (minimal travel in the prior year due to the pandemic). The G&A expenses rate increased by 0.3 ppt. in the current-year period, compared with the same period one year ago due to the deleveraging impact of the 7% net sales decrease, in addition to the items discussed above.

Research and development expenses

Research and development (R&D) expenses increased by 23% to $16 million for the three months ended April 2, 2022, compared with $13 million for the same period last year as we continued to prioritize our long-term innovation initiatives.

17 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

Interest expense

Interest expense, net increased to $2 million for the three months ended April 2, 2022, compared with $1 million for the same period one year ago. The $1 million increase was mainly driven by a higher level of outstanding borrowings during the three months ended April 2, 2022 compared with the same period in 2021, and a higher weighted-average interest rate compared with the same period one year ago.

Income tax expense

Income tax expense totaled $0.2 million for the three months ended April 2, 2022, compared with $8.8 million last year. The effective income tax rate for the three months ended April 2, 2022 was 9.4%, compared with 11.7% for the comparable period last year. Discrete tax benefits, primarily stock-based compensation excess tax benefits, were $0.4 million for the three months ended April 2, 2022, compared with $10.0 million in last year’s first quarter.

Liquidity and Capital Resources

Managing our liquidity and capital resources is an important part of our commitment to deliver superior shareholder value over time. Our primary sources of liquidity are cash flows provided by operating activities and cash available under our $825 million revolving credit facility. As of April 2, 2022, we do not have any off-balance sheet financing other than our $6 million in outstanding letters of credit. The cash generated from ongoing operations and cash available under our revolving credit facility are expected to be adequate to maintain operations, and fund anticipated expansion, strategic initiatives and contractual obligations such as lease payments and capital commitments for new retail stores for the foreseeable future.

Changes in cash and cash equivalents during the three months ended April 2, 2022 primarily consisted of $25 million of cash provided by operating activities and a $45 million net increase in short-term borrowings, offset by $20 million of cash used to purchase property and equipment, and $51 million of cash used to repurchase our common stock (based on settlement, $42 million under our Board-approved share repurchase program and $9 million in connection with the vesting of employee restricted stock grants).

The following table summarizes our cash flows (in millions). Amounts may not add due to rounding differences:

	Three Months Ended
	April 2, 2022		April 3, 2021
Total cash provided by (used in):
Operating activities	$	24.6	$	111.6
Investing activities	(19.6)		(11.5)
Financing activities	(5.8)		(102.1)
Net decrease in cash and cash equivalents	$	(0.8)	$	(2.0)

Cash provided by operating activities for the three months ended April 2, 2022 was $25 million, compared with $112 million for the three months ended April 3, 2021. Significant components of the year-over-year change in cash provided by operating activities included: (i) a $65 million decrease in net income for the three months ended April 2, 2022, compared with the same period one year ago; (ii) a $14 million fluctuation in prepaid expenses and other assets due to both periods being impacted by the timing of rent payments and a reduction in business activities due to the pandemic; (iii) a $12 million change in other accruals and liabilities due to the timing of payments; (iv) a $10 million fluctuation in accounts payable with both periods impacted by business changes and timing of payments; and (v) a $9 million fluctuation in the amount of compensation and benefits accrued and timing of the related payments resulting from year-over-year changes in Company-wide performance-based incentive compensation.

Net cash used in investing activities to purchase property and equipment was $20 million for the three months ended April 2, 2022, compared with $12 million for the same period one year ago. The year-over-year increase was primarily due to the timing of cash flows associated with new and remodeled stores’ property and equipment, and investments in information technology.

Net cash used in financing activities was $6 million for the three months ended April 2, 2022, compared with $102 million for the same period last year. During the three months ended April 2, 2022, we repurchased $51 million of

18 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

our stock (based on settlement dates, $42 million under our Board-approved share repurchase program and $9 million in connection with the vesting of employee restricted stock awards), compared with $179 million during the same period one year ago. Short-term borrowings increased by $45 million during the current-year period due to a $31 million increase in borrowings under our revolving credit facility to $413 million and a $14 million increase in book overdrafts which are included in the net change in short-term borrowings. Short-term borrowings increased by $74 million during the prior-year period due to a $71 million increase in borrowings under our credit facility to $315 million and a $3 million increase in book overdrafts.

Under our Board-approved share repurchase program, we repurchased 0.7 million shares at a cost of $42 million (based on trade dates, an average of $63.95 per share) during the three months ended April 2, 2022. During the three months ended April 3, 2021, we repurchased 1.2 million shares at a cost of $167 million (based on trade dates, an average of $136.27 per share). There is no expiration date governing the period over which we can repurchase shares. At April 2, 2022, there is $361 million remaining authorization under our Board-approved $600 million share repurchase program.

As of April 2, 2022, we had $413 million of borrowings under our revolving credit facility. We also had $6 million in outstanding letters of credit. Net liquidity available under our credit facility was $406 million at April 2, 2022. The credit agreement provides the lenders with a collateral security interest in substantially all of our assets and those of our subsidiaries and requires us to comply with, among other things, a maximum leverage ratio (4.5x) and a minimum interest coverage ratio (3.0x). Our leverage ratio as defined in our credit agreement was 3.4x as of April 2, 2022. Under the terms of the credit agreement, we pay a variable rate of interest and a commitment fee based on our leverage ratio. The credit agreement is for general corporate purposes, to meet our seasonal working capital requirements and to repurchase our stock. As of April 2, 2022, the weighted-average interest rate on borrowings under the credit facility was 2.2% and we were in compliance with all financial covenants.

We have an agreement with Synchrony Bank to offer qualified customers revolving credit arrangements to finance their purchases from us (Synchrony Agreement). The Synchrony Agreement contains financial covenants consistent with our credit facility, including a maximum leverage ratio and a minimum interest coverage ratio. As of April 2, 2022, we were in compliance with all financial covenants.

Under the terms of the Synchrony Agreement, Synchrony Bank sets the minimum acceptable credit ratings, the interest rates, fees and all other terms and conditions of the customer accounts, including collection policies and procedures, and is the owner of the accounts. As the accounts are owned by Synchrony Bank, at no time are the accounts purchased or acquired from us. We are not liable to Synchrony Bank for our customers’ credit defaults.

19 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

Non-GAAP Data Reconciliations

Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)

We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net income plus: income tax expense, interest expense, depreciation and amortization, stock-based compensation and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure.

Our Adjusted EBITDA calculations are as follows (in thousands):

	Three Months Ended				Trailing-Twelve Months Ended
	April 2, 2022		April 3, 2021		April 2, 2022		April 3, 2021
Net income	$	2,074	$	66,634	$	89,186	$	166,683
Income tax expense	214		8,812		24,947		34,265
Interest expense	2,127		978		7,394		7,642
Depreciation and amortization	15,683		14,519		60,943		60,049
Stock-based compensation	4,133		6,417		20,930		26,179
Asset impairments	103		89		186		388
Adjusted EBITDA	$	24,334	$	97,449	$	203,586	$	295,206

Free Cash Flow

Our “free cash flow” data is considered a non-GAAP financial measure and is not in accordance with, or preferable to, “net cash provided by operating activities,” or GAAP financial data. However, we are providing this information as we believe it facilitates analysis for investors and financial analysts.

The following table summarizes our free cash flow calculations (in thousands):

	Three Months Ended				Trailing-Twelve Months Ended
	April 2, 2022		April 3, 2021		April 2, 2022		April 3, 2021
Net cash provided by operating activities	$	24,558	$	111,598	$	212,970	$	306,318
Subtract: Purchases of property and equipment	19,604		11,546		74,958		38,295
Free cash flow	$	4,954	$	100,052	$	138,012	$	268,023

20 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

Non-GAAP Data Reconciliations (continued)

Return on Invested Capital (ROIC)

(dollars in thousands)

ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our invested capital. Management believes ROIC is also a useful metric for investors and financial analysts. We compute ROIC as outlined below. Our definition and calculation of ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile net operating profit after taxes (NOPAT) and total invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures:

	Trailing-Twelve Months Ended
	April 2, 2022			April 3, 2021
Net operating profit after taxes (NOPAT)
Operating income	$	121,527		$	208,506
Add: Rent expense (1)	104,937			92,650
Add: Interest income	—			84
Less: Depreciation on capitalized operating leases (2)	(26,311)			(24,258)
Less: Income taxes (3)	(47,503)			(66,118)
NOPAT	$	152,650		$	210,864
Average invested capital
Total deficit	$	(469,213)		$	(332,650)
Add: Long-term debt (4)	413,709			315,522
Add: Capitalized operating lease obligations (5)	839,496			741,200
Total invested capital at end of period	$	783,992		$	724,072
Average invested capital (6)	$	746,167		$	763,227
Return on invested capital (ROIC) (7)	20.5		%	27.6		%

___________________________

(1)Rent expense is added back to operating income to show the impact of owning versus leasing the related assets.

(2)Depreciation is based on the average of the last five fiscal quarters' ending capitalized operating lease obligations (see note 5) for the respective reporting periods with an assumed thirty-year useful life. This life assumption is based on our long-term participation in given markets though specific retail location lease commitments are generally 5 to 10 years at inception. This is subtracted from operating income to illustrate the impact of owning versus leasing the related assets.

(3)Reflects annual effective income tax rates, before discrete adjustments, of 23.7% and 23.9% for 2022 and 2021, respectively.

(4)Long-term debt includes existing finance lease liabilities.

(5)A multiple of eight times annual rent expense is used as an estimate for capitalizing our operating lease obligations. The methodology utilized aligns with the methodology of a nationally recognized credit rating agency.

(6)Average invested capital represents the average of the last five fiscal quarters' ending invested capital balances.

(7)ROIC equals NOPAT divided by average invested capital.

Note - Our ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

GAAP - generally accepted accounting principles in the U.S.

21 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

Off-Balance-Sheet Arrangements

As of April 2, 2022, we were not involved in any unconsolidated special purpose entity transactions. Other than our $6 million in outstanding letters of credit, we do not have any off-balance-sheet financing.

There have been no material changes in our contractual obligations since the end of fiscal 2021. See Note 5, Credit Agreement, of the Notes to our Condensed Consolidated Financial Statements for information regarding our credit agreement. See our Annual Report on Form 10-K for the fiscal year ended January 1, 2022 for additional information regarding our other contractual obligations.

Critical Accounting Policies

We discuss our critical accounting policies and estimates in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended January 1, 2022. There were no significant changes in our critical accounting policies since the end of fiscal 2021.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to changes in market-based short-term interest rates that will impact our net interest expense. If overall interest rates were one percentage point higher than current rates, our annual net income would decrease by $3.1 million based on the $413 million of borrowings under our credit facility at April 2, 2022. We do not manage the interest-rate volatility risk of borrowings under our credit facility through the use of derivative instruments.

ITEM 4. CONTROLS AND PROCEDURES

Conclusions Regarding the Effectiveness of Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as defined in Exchange Act Rule 13a-15(e), that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including its principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this quarterly report. Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this quarterly report.

Changes in Internal Control

There were no changes in our internal control over financial reporting during the fiscal quarter ended April 2, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

22 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

PART II: OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Our legal proceedings are discussed in Note 12, Commitments and Contingencies, Legal Proceedings, in the Notes to Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

ITEM 1A. RISK FACTORS

Our business, financial condition and operating results are subject to a number of risks and uncertainties, including both those that are specific to our business and others that affect all businesses operating in a global environment. Investors should carefully consider the information in this report under the heading, Management’s Discussion and Analysis of Financial Condition and Results of Operations, and also the information under the heading, Risk Factors, in our most recent Annual Report on Form 10-K. The risk factors discussed in the Annual Report on Form 10-K and in this Quarterly Report on Form 10-Q do not identify all risks that we face because our business operations could also be affected by additional risk factors that are not presently known to us or that we currently consider to be immaterial to our operations.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

(a) – (b) Not applicable.

(c) Issuer Purchases of Equity Securities

Period	Total Number of Shares Purchased(1)(2)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(1)	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs(3)
January 2, 2022 through January 29, 2022	396	$	86.60	—	$	402,939,000
January 30, 2022 through February 26, 2022	59,272	$	81.41	58,487	$	399,093,000
February 27, 2022 through April 2, 2022	753,687	$	77.47	603,053	$	360,631,000
Total	813,355	$	82.82	661,540	$	360,631,000

___________________________

(1)Under our Board-approved $600 million share repurchase program (effective April 4, 2021), we repurchased 0.7 million shares of our common stock at a cost of $42 million (based on trade dates) during the three months ended April 2, 2022.

(2)In connection with the vesting of employee restricted stock grants, we repurchased 151,815 shares of our common stock at a cost of $8.7 million during the three months ended April 2, 2022.

(3)There is no expiration date governing the period over which we can repurchase shares under our Board-approved share repurchase program. Any repurchased shares are constructively retired and returned to an unissued status.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

Not applicable.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

Not applicable.

23 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

ITEM 6. EXHIBITS

Exhibit Number	Description
10.1	Seventh Amendment to Amended and Restated Credit and Security Agreement (incorporated by reference to Exhibit 10.36 contained in Sleep Number’s Annual Report on Form 10-K filed March 1, 2022 (File No. 000-25121))
31.1*	Certification of CEO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*	Certification of CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*	Certification of CEO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350
32.2*	Certification of CFO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350
101.INS*	Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH*	Inline XBRL Taxonomy Extension Schema Document
101.CAL*	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*	Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

* Filed Herewith

24 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		SLEEP NUMBER CORPORATION
		(Registrant)
Dated:	April 29, 2022	By:	/s/ Shelly R. Ibach
			Shelly R. Ibach
			Chief Executive Officer
			(principal executive officer)
		By:	/s/ Joel J. Laing
			Joel J. Laing
			Chief Accounting Officer
			(principal accounting officer)

25 | 1Q 2022 FORM 10-Q SLEEP NUMBER CORPORATION

EX-31.1

Exhibit 31.1

Certification by Chief Executive Officer

I, Shelly R. Ibach, certify that:

1.I have reviewed this Quarterly report on Form 10-Q of Sleep Number Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)), for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:    April 29, 2022
	/s/ Shelly R. Ibach
	Shelly R. Ibach
	Chief Executive Officer

EX-31.2

Exhibit 31.2

Certification by Chief Financial Officer

I, David R. Callen, certify that:

1.I have reviewed this Quarterly report on Form 10-Q of Sleep Number Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)), for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:    April 29, 2022
	/s/ David R. Callen
	David R. Callen
	Executive Vice President and Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Sleep Number Corporation (the “Company”) on Form 10-Q for the period ended April 2, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Shelly R. Ibach, Chief Executive Officer of the Company, solely for the purposes of 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, does hereby certify, to her knowledge, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:    April 29, 2022
	/s/ Shelly R. Ibach
	Shelly R. Ibach
	Chief Executive Officer

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Sleep Number Corporation (the “Company”) on Form 10-Q for the period ended April 2, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, David R. Callen, Executive Vice President and Chief Financial Officer of the Company, solely for the purposes of 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, does hereby certify, to his knowledge, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:    April 29, 2022
	/s/ David R. Callen
	David R. Callen
	Executive Vice President and Chief Financial Officer

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

XML

Cover Page shares in Thousands	3 Months Ended
	Apr. 02, 2022 shares
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 02, 2022
Document Transition Report	false
Entity File Number	000-25121
Entity Registrant Name	SLEEP NUMBER CORPORATION
Entity Incorporation, State or Country Code	MN
Entity Tax Identification Number	41-1597886
Entity Address, Address Line One	1001 Third Avenue South
Entity Address, City or Town	Minneapolis,
Entity Address, State or Province	MN
Entity Address, Postal Zip Code	55404
City Area Code	763
Local Phone Number	551-7000
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	SNBR
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	22,232
Entity Central Index Key	0000827187
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Amendment Flag	false

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Apr. 02, 2022	Jan. 01, 2022
Current assets:
Cash and cash equivalents	$ 1,556	$ 2,389
Accounts receivable, net of allowances of $1,047 and $924, respectively	24,502	25,718
Inventories	103,212	105,644
Prepaid expenses	22,001	18,953
Other current assets	40,624	54,917
Total current assets	191,895	207,621
Non-current assets:
Property and equipment, net	197,644	195,128
Operating lease right-of-use assets	374,650	371,133
Goodwill and intangible assets, net	69,867	70,468
Other non-current assets	78,529	75,190
Total assets	912,585	919,540
Current liabilities:
Borrowings under revolving credit facility	413,200	382,500
Accounts payable	177,025	162,547
Customer prepayments	142,005	129,499
Accrued sales returns	20,277	22,368
Compensation and benefits	25,702	51,240
Taxes and withholding	26,293	22,087
Operating lease liabilities	74,046	72,360
Other current liabilities	59,390	64,177
Total current liabilities	937,938	906,778
Non-current liabilities:
Deferred income taxes	312	688
Operating lease liabilities	338,528	336,192
Other non-current liabilities	105,020	100,835
Total liabilities	1,381,798	1,344,493
Shareholders’ deficit:
Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding	0	0
Common stock, $0.01 par value; 142,500 shares authorized, 22,232 and 22,683 shares issued and outstanding, respectively	222	227
Additional paid-in capital	0	3,971
Accumulated deficit	(469,435)	(429,151)
Total shareholders’ deficit	(469,213)	(424,953)
Total liabilities and shareholders’ deficit	$ 912,585	$ 919,540

XML

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Apr. 02, 2022	Jan. 01, 2022
Current assets:
Allowances	$ 1,047	$ 924
Shareholders’ deficit:
Undesignated preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Undesignated preferred stock, shares issued (in shares)	0	0
Undesignated preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	142,500,000	142,500,000
Common stock, shares issued (in shares)	22,232,000	22,683,000
Common stock, shares outstanding (in shares)	22,232,000	22,683,000

XML

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Apr. 02, 2022	Apr. 03, 2021
Income Statement [Abstract]
Net sales	$ 527,130	$ 568,256
Cost of sales	224,832	212,338
Gross profit	302,298	355,918
Operating expenses:
Sales and marketing	240,259	223,617
General and administrative	41,319	42,592
Research and development	16,305	13,286
Total operating expenses	297,883	279,495
Operating income	4,415	76,423
Interest expense, net	2,127	977
Income before income taxes	2,288	75,446
Income tax expense	214	8,812
Net income	$ 2,074	$ 66,634
Basic net income per share:
Net income per share – basic (in dollars per share)	$ 0.09	$ 2.63
Weighted-average shares – basic (in shares)	22,760,000	25,377,000
Diluted net income per share:
Net income per share – diluted (in dollars per share)	$ 0.09	$ 2.51
Weighted-average shares – diluted (in shares)	23,591,000	26,544,000

XML

Condensed Consolidated Statements of Shareholders' (Deficit) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Jan. 02, 2021		25,390
Beginning balance at Jan. 02, 2021	$ (223,978)	$ 254	$ 0	$ (224,232)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	66,634			66,634
Exercise of common stock options (in shares)		106
Exercise of common stock options	2,460	$ 1	2,459
Stock-based compensation (in shares)		314
Stock-based compensation	6,416	$ 3	6,413
Repurchases of common stock (in shares)		(1,346)
Repurchases of common stock	(184,182)	$ (13)	(8,872)	(175,297)
Ending balance (in shares) at Apr. 03, 2021		24,464
Ending balance at Apr. 03, 2021	$ (332,650)	$ 245	0	(332,895)
Beginning balance (in shares) at Jan. 01, 2022	22,683	22,683
Beginning balance at Jan. 01, 2022	$ (424,953)	$ 227	3,971	(429,151)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,074			2,074
Exercise of common stock options (in shares)		21
Exercise of common stock options	531		531
Stock-based compensation (in shares)		341
Stock-based compensation	4,133	$ 3	4,130
Repurchases of common stock (in shares)		(813)
Repurchases of common stock	$ (50,998)	$ (8)	(8,632)	(42,358)
Ending balance (in shares) at Apr. 02, 2022	22,232	22,232
Ending balance at Apr. 02, 2022	$ (469,213)	$ 222	$ 0	$ (469,435)

XML

Condensed Consolidated Statement of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Apr. 02, 2022	Apr. 03, 2021
Cash flows from operating activities:
Net income	$ 2,074	$ 66,634
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	15,870	14,638
Stock-based compensation	4,133	6,416
Net loss on disposals and impairments of assets	93	78
Deferred income taxes	(376)	1,515
Changes in operating assets and liabilities:
Accounts receivable	1,216	5,948
Inventories	2,432	(946)
Income taxes	1,102	6,847
Prepaid expenses and other assets	10,877	(3,113)
Accounts payable	2,073	12,390
Customer prepayments	12,506	20,552
Accrued compensation and benefits	(25,348)	(34,605)
Other taxes and withholding	3,104	8,912
Other accruals and liabilities	(5,198)	6,332
Net cash provided by operating activities	24,558	111,598
Cash flows from investing activities:
Purchases of property and equipment	(19,604)	(11,546)
Proceeds from sales of property and equipment	10	12
Net cash used in investing activities	(19,594)	(11,534)
Cash flows from financing activities:
Repurchases of common stock	(50,998)	(178,613)
Net increase in short-term borrowings	44,712	74,087
Proceeds from issuance of common stock	531	2,460
Debt issuance costs	(42)	(3)
Net cash used in financing activities	(5,797)	(102,069)
Net decrease in cash and cash equivalents	(833)	(2,005)
Cash and cash equivalents, at beginning of period	2,389	4,243
Cash and cash equivalents, at end of period	$ 1,556	$ 2,238

XML

Business and Summary of Significant Accounting Policies

3 Months Ended

Apr. 02, 2022

Accounting Policies [Abstract]

Business and Summary of Significant Accounting Policies

Business and Summary of Significant Accounting Policies

Business & Basis of Presentation

We prepared the condensed consolidated financial statements as of and for the three months ended April 2, 2022 of Sleep Number Corporation and our 100%-owned subsidiaries (Sleep Number or the Company), without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) and they reflect, in the opinion of management, all normal recurring adjustments necessary to present fairly our financial position as of April 2, 2022 and January 1, 2022, and the consolidated results of operations and cash flows for the periods presented. Our historical and quarterly consolidated results of operations may not be indicative of the results that may be achieved for the full year or any future period. In addition, based on the duration and severity of the current global situation involving the COVID-19 pandemic, the war in Ukraine and other external factors, including but not limited to general economic conditions, inflation, consumer confidence, store restrictions mandated by federal, state or local authorities and global supply chain disruptions, the extent to which these external factors will impact our business and our consolidated financial results will depend on future developments, which are highly uncertain and cannot be predicted.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP) have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements should be read in conjunction with our most recent audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended January 1, 2022 and other recent filings with the SEC.

The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of sales, expenses and income taxes during the reporting period. Predicting future events is inherently an imprecise activity and, as such, requires the use of judgment. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. In addition, during the current environment involving external factors such as COVID-19 and the war in Ukraine, predicting future events will be especially challenging for management. Changes in these estimates will be reflected in the consolidated financial statements in future periods and could be material. Our critical accounting policies consist of stock-based compensation, warranty liabilities and revenue recognition.

The condensed consolidated financial statements include the accounts of Sleep Number Corporation and our 100%-owned subsidiaries. All significant intra-entity balances and transactions have been eliminated in consolidation.

XML

Fair Value Measurements	3 Months Ended
	Apr. 02, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value MeasurementsAt April 2, 2022 and January 1, 2022, we had $18 million and $19 million, respectively, of debt and equity securities that fund our deferred compensation plan and are classified in other non-current assets. We also had corresponding deferred compensation plan liabilities of $18 million and $19 million at April 2, 2022 and January 1, 2022, respectively, which are included in other non-current liabilities. The majority of the debt and equity securities are Level 1 as they trade with sufficient frequency and volume to enable us to obtain pricing information on an ongoing basis. Unrealized gains/(losses) on the debt and equity securities offset those associated with the corresponding deferred compensation plan liabilities.

XML

Inventories

3 Months Ended

Apr. 02, 2022

Inventory Disclosure [Abstract]

Inventories

InventoriesInventories consisted of the following (in thousands):

	April 2, 2022		January 1, 2022
Raw materials	$	11,257	$	11,752
Work in progress	68		83
Finished goods	91,887		93,809
	$	103,212	$	105,644

XML

Goodwill and Intangible Assets, Net

3 Months Ended

Apr. 02, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets, Net

Goodwill and Intangible Assets, Net

Goodwill and Indefinite-lived Intangible Assets

Goodwill was $64 million at April 2, 2022 and January 1, 2022. Indefinite-lived trade name/trademarks totaled $1.4 million at April 2, 2022 and January 1, 2022.

Definite-lived Intangible Assets

The gross carrying amount of our developed technologies was $19 million at April 2, 2022 and January 1, 2022. Accumulated amortization was $16 million at April 2, 2022 and January 1, 2022. Amortization expense for both the three months ended April 2, 2022 and April 3, 2021, was $0.5 million.

The gross carrying amount of our patents was $2 million at April 2, 2022 and January 1, 2022. Accumulated amortization was $0.4 million and $0.3 million at April 2, 2022 and January 1, 2022, respectively. Amortization expense for both the three months ended April 2, 2022 and April 3, 2021, was $55 thousand.

Annual amortization for definite-lived intangible assets for subsequent years are as follows (in thousands):

2022 (excluding the three months ended April 2, 2022)	$	1,802
2023	1,431
2024	222
2025	226
2026	222
2027	222
Thereafter	300
Total future amortization for definite-lived intangible assets	$	4,425

XML

Credit Agreement

3 Months Ended

Apr. 02, 2022

Debt Disclosure [Abstract]

Credit Agreement

Credit AgreementAs of April 2, 2022, our credit facility had a total commitment amount of $825 million. The credit facility is for general corporate purposes, to meet our seasonal working capital requirements and to repurchase our stock. The credit agreement includes an accordion feature which allows us to increase the amount of the credit facility from $825 million to $1.2 billion, subject to lenders’ approval. The credit agreement provides the lenders with a collateral security interest in substantially all of our assets and those of our subsidiaries and requires us to comply with, among other things, a maximum leverage ratio (4.5x) and a minimum interest coverage ratio (3.0x). Under the terms of the credit agreement, we pay a variable rate of interest and a commitment fee based on our leverage ratio. The credit agreement matures in December 2026. We were in compliance with all financial covenants as of April 2, 2022.The following table summarizes our borrowings under the credit facility ($ in thousands):

	April 2, 2022			January 1, 2022
Outstanding borrowings	$	413,200		$	382,500
Outstanding letters of credit	$	5,947		$	3,997
Additional borrowing capacity	$	405,853		$	438,503
Weighted-average interest rate	2.2		%	1.6		%

XML

Leases

3 Months Ended

Apr. 02, 2022

Leases [Abstract]

Leases

Leases

We lease our retail, office and manufacturing space under operating leases which, in addition to the minimum lease payments, may require payment of a proportionate share of the real estate taxes and certain building operating expenses. While our local market development approach generally results in long-term participation in given markets, our retail store leases generally provide for an initial lease term of five to 10 years. Our office and manufacturing leases provide for an initial lease term of up to 15 years. In addition, our mall-based retail store leases may require payment of variable rent based on net sales in excess of certain thresholds. Certain leases may contain options to extend the term of the original lease. The exercise of lease renewal options is at our sole discretion. Lease options are included in the lease term only if exercise is reasonably certain at lease commencement. Our lease agreements do not contain any material residual value guarantees. We also lease vehicles and certain equipment under operating leases with an initial lease term of three to five years.

Our operating lease costs include facility, vehicle and equipment lease costs, but exclude variable lease costs. Operating lease costs are recognized on a straight-line basis over the lease term, after consideration of rent escalations and rent holidays. The lease term for purposes of the calculation begins on the earlier of the lease commencement date or the date we take possession of the property. During lease renewal negotiations that extend beyond the original lease term, we estimate straight-line rent expense based on current market conditions. Variable lease costs are recorded when it is probable the cost has been incurred and the amount can be reasonably estimated. Future payments for real estate taxes and certain building operating expenses for which we are obligated are not included in operating lease costs.

At April 2, 2022, our finance right-of-use assets and lease liabilities were not significant.

Lease costs were as follows (in thousands):

	Three Months Ended
	April 2, 2022		April 3, 2021
Operating lease costs(1)	$	27,078	$	23,638
Variable lease costs	$	330	$	515

___________________________

(1)Includes short-term lease costs which are not significant.

The maturities of operating lease liabilities as of April 2, 2022, were as follows(1) (in thousands):

2022 (excluding the three months ended April 2, 2022)	$	72,962
2023	89,790
2024	77,978
2025	68,001
2026	56,694
2027	41,517
Thereafter	86,958
Total operating lease payments(2)	493,900
Less: Interest	81,326
Present value of operating lease liabilities	$	412,574

___________________________

(1)Total operating lease payments exclude $102 million of legally binding minimum lease payments for leases signed but not yet commenced.

(2)Includes the current portion of $74 million for operating lease liabilities.

Other information related to operating leases was as follows:

	April 2, 2022		January 1, 2022
Weighted-average remaining lease term (years)	6.3		6.4
Weighted-average discount rate	6.0	%	6.1	%

	Three Months Ended
(in thousands)	April 2, 2022		April 3, 2021
Cash paid for amounts included in present value of operating lease liabilities	$	24,209	$	21,386
Right-of-use assets obtained in exchange for operating lease liabilities	$	17,564	$	29,454

XML

Repurchases of Common Stock

3 Months Ended

Apr. 02, 2022

Repurchases Of Common Stock [Abstract]

Repurchases of Common Stock

Repurchases of Common Stock

Repurchases of our common stock were as follows (in thousands):

	Three Months Ended
	April 2, 2022		April 3, 2021
Amount repurchased under Board-approved share repurchase program	$	42,308	$	167,418
Amount repurchased in connection with the vesting of employee restricted stock grants	8,690		16,764
Total amount repurchased (based on trade dates)	$	50,998	$	184,182

As of April 2, 2022, the remaining authorization under the $600 million share repurchase program was $361 million.

XML

Revenue Recognition

3 Months Ended

Apr. 02, 2022

Revenue from Contract with Customer [Abstract]

Revenue Recognition

Revenue Recognition

Deferred contract assets and deferred contract liabilities are included in our condensed consolidated balance sheets as follows (in thousands):

	April 2, 2022		January 1, 2022
Deferred contract assets included in:
Other current assets	$	26,926	$	28,048
Other non-current assets	53,244		49,343
	$	80,170	$	77,391

	April 2, 2022		January 1, 2022
Deferred contract liabilities included in:
Other current liabilities	$	34,999	$	36,490
Other non-current liabilities	68,657		63,680
	$	103,656	$	100,170

The deferred revenue and costs related to SleepIQ® technology are currently recognized on a straight-line basis over the product's estimated life of 4.5 to 5.0 years because our inputs are generally expended evenly throughout the performance period. During the three months ended April 2, 2022 and April 3, 2021, we recognized revenue of $9 million and $7 million, respectively, that were included in the deferred contract liability balances at the beginning of the respective periods.

Revenue from goods and services transferred to customers at a point in time accounted for approximately 98% of our revenues for the three months ended April 2, 2022 and 99% of our revenues for the three months ended April 3, 2021.

Net sales were as follows (in thousands):

	Three Months Ended
	April 2, 2022		April 3, 2021
Retail stores	$	444,336	$	489,188
Online, phone, chat and other	82,794		79,068
Total Company	$	527,130	$	568,256

Obligation for Sales Returns

The activity in the sales returns liability account was as follows (in thousands):

	Three Months Ended
	April 2, 2022		April 3, 2021
Balance at beginning of year	$	22,368	$	24,765
Additions that reduce net sales	26,667		23,711
Deductions from reserves	(28,758)		(23,866)
Balance at end of period	$	20,277	$	24,610

XML

Stock-based Compensation Expense

3 Months Ended

Apr. 02, 2022

Share-based Payment Arrangement [Abstract]

Stock-based Compensation Expense

Stock-based Compensation Expense

Total stock-based compensation expense was as follows (in thousands):

	Three Months Ended
	April 2, 2022		April 3, 2021
Stock awards	$	3,274	$	5,808
Stock options	859		608
Total stock-based compensation expense (1)	4,133		6,416
Income tax benefit	1,033		1,598
Total stock-based compensation expense, net of tax	$	3,100	$	4,818

___________________________

(1) Changes in stock-based compensation expense reflect the cumulative impact of the change in the expected achievements of certain performance targets.

XML

Profit Sharing and 401(k) Plan	3 Months Ended
	Apr. 02, 2022
Profit Sharing And 401 (k) Plan [Abstract]
Profit Sharing and 401(k) Plan	Profit Sharing and 401(k) PlanUnder our profit sharing and 401(k) plan, eligible employees may defer up to 50% of their compensation on a pre-tax basis, subject to Internal Revenue Service limitations. Each pay period, we may make a discretionary contribution equal to a percentage of the employee’s contribution. During the three months ended April 2, 2022 and April 3, 2021, our contributions, net of forfeitures, were $2.8 million and $1.9 million, respectively.

XML

Net Income per Common Share

3 Months Ended

Apr. 02, 2022

Earnings Per Share [Abstract]

Net Income per Common Share

Net Income per Common ShareThe components of basic and diluted net income per share were as follows (in thousands, except per share amounts):

	Three Months Ended
	April 2, 2022		April 3, 2021
Net income	$	2,074	$	66,634
Reconciliation of weighted-average shares outstanding:
Basic weighted-average shares outstanding	22,760		25,377
Dilutive effect of stock-based awards	831		1,167
Diluted weighted-average shares outstanding	23,591		26,544
Net income per share – basic	$	0.09	$	2.63
Net income per share – diluted	$	0.09	$	2.51

For the three months ended April 2, 2022 and April 3, 2021, anti-dilutive stock-based awards excluded from the diluted net income per share calculations were immaterial.

XML

Commitments and Contingencies

3 Months Ended

Apr. 02, 2022

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Warranty Liabilities

The activity in the accrued warranty liabilities account was as follows (in thousands):

	Three Months Ended
	April 2, 2022		April 3, 2021
Balance at beginning of year	$	10,069	$	12,152
Additions charged to costs and expenses for current-year sales	4,447		4,330
Deductions from reserves	(4,750)		(4,717)
Changes in liability for pre-existing warranties during the current year, including expirations	(31)		(156)
Balance at end of period	$	9,735	$	11,609

Legal Proceedings

We are involved from time to time in various legal proceedings arising in the ordinary course of our business, including primarily commercial, product liability, employment and intellectual property claims. In accordance with U.S. generally accepted accounting principles, we record a liability in our consolidated financial statements with respect to any of these matters when it is both probable that a liability has been incurred and the amount of the liability can be reasonably estimated. If a material loss is reasonably possible but not known or probable, and may be reasonably estimated, the estimated loss or range of loss is disclosed. With respect to currently pending legal proceedings, we have not established an estimated range of reasonably possible material losses either because we believe that we have valid defenses to claims asserted against us, the proceeding has not advanced to a stage of discovery that would enable us to establish an estimate, or the potential loss is not material. We currently do not expect the outcome of pending legal proceedings to have a material effect on our consolidated results of operations, financial position or cash flows. Litigation, however, is inherently unpredictable, and it is possible that the ultimate outcome of one or more claims asserted against us could adversely impact our consolidated results of operations, financial position or cash flows. We expense legal costs as incurred.

On December 14, 2021, Steamfitters Local 449 Pension & Retirement Security Funds filed a putative class action complaint in the United States District Court for the District of Minnesota on behalf of all purchasers of Sleep Number common stock between February 18, 2021 and July 20, 2021, inclusive, against Sleep Number, Shelly Ibach and David Callen. Plaintiff alleges material misstatements and omissions in certain of Sleep Number’s public disclosures during the purported class period, in violation of Section 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended. The complaint seeks, among other things, unspecified monetary damages, reasonable costs and expenses and equitable/injunctive or other relief as deemed appropriate by the Court. We believe these claims are without merit and intend to vigorously defend the matter.

XML

COVID-19 Pandemic	3 Months Ended
	Apr. 02, 2022
Unusual or Infrequent Items, or Both [Abstract]
COVID-19 Pandemic	COVID-19 PandemicThe COVID-19 pandemic impacted our 2021 and 2022 financial performance. In the first quarter of 2021, even with the COVID-19 challenges, we generated strong demand and financial performance. In the first quarter of 2022, our financial performance was impacted by: (i) the disruptive flow of semiconductor chips which affected our ability to deliver products to our customers and suppressed consumer confidence; (ii) incremental costs from labor and material inflation, and expediting costs resulting from current-period global supply chain shortages; and (iii) increased investments in our long- and near-term innovations and demand drivers, partly offset by cost containment actions. The pandemic's future effects on our global supply chain and the potential for supply disruption (e.g., the lack or slowing of critical components caused by labor shortages or government-mandated work closures), effects on consumer demand and effects on our ongoing financial performance remains uncertain. See Part II, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations and Part II: Item 1A. Risk Factors for additional discussion on the COVID-19 pandemic and the impact on our business.

XML

Business and Summary of Significant Accounting Policies (Policies)

3 Months Ended

Apr. 02, 2022

Accounting Policies [Abstract]

Business & Basis of Presentation

Business & Basis of Presentation

We prepared the condensed consolidated financial statements as of and for the three months ended April 2, 2022 of Sleep Number Corporation and our 100%-owned subsidiaries (Sleep Number or the Company), without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) and they reflect, in the opinion of management, all normal recurring adjustments necessary to present fairly our financial position as of April 2, 2022 and January 1, 2022, and the consolidated results of operations and cash flows for the periods presented. Our historical and quarterly consolidated results of operations may not be indicative of the results that may be achieved for the full year or any future period. In addition, based on the duration and severity of the current global situation involving the COVID-19 pandemic, the war in Ukraine and other external factors, including but not limited to general economic conditions, inflation, consumer confidence, store restrictions mandated by federal, state or local authorities and global supply chain disruptions, the extent to which these external factors will impact our business and our consolidated financial results will depend on future developments, which are highly uncertain and cannot be predicted.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP) have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements should be read in conjunction with our most recent audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended January 1, 2022 and other recent filings with the SEC.

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of sales, expenses and income taxes during the reporting period. Predicting future events is inherently an imprecise activity and, as such, requires the use of judgment. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. In addition, during the current environment involving external factors such as COVID-19 and the war in Ukraine, predicting future events will be especially challenging for management. Changes in these estimates will be reflected in the consolidated financial statements in future periods and could be material. Our critical accounting policies consist of stock-based compensation, warranty liabilities and revenue recognition.

Consolidation

The condensed consolidated financial statements include the accounts of Sleep Number Corporation and our 100%-owned subsidiaries. All significant intra-entity balances and transactions have been eliminated in consolidation.

Leases

We lease our retail, office and manufacturing space under operating leases which, in addition to the minimum lease payments, may require payment of a proportionate share of the real estate taxes and certain building operating expenses. While our local market development approach generally results in long-term participation in given markets, our retail store leases generally provide for an initial lease term of five to 10 years. Our office and manufacturing leases provide for an initial lease term of up to 15 years. In addition, our mall-based retail store leases may require payment of variable rent based on net sales in excess of certain thresholds. Certain leases may contain options to extend the term of the original lease. The exercise of lease renewal options is at our sole discretion. Lease options are included in the lease term only if exercise is reasonably certain at lease commencement. Our lease agreements do not contain any material residual value guarantees. We also lease vehicles and certain equipment under operating leases with an initial lease term of three to five years.

Our operating lease costs include facility, vehicle and equipment lease costs, but exclude variable lease costs. Operating lease costs are recognized on a straight-line basis over the lease term, after consideration of rent escalations and rent holidays. The lease term for purposes of the calculation begins on the earlier of the lease commencement date or the date we take possession of the property. During lease renewal negotiations that extend beyond the original lease term, we estimate straight-line rent expense based on current market conditions. Variable lease costs are recorded when it is probable the cost has been incurred and the amount can be reasonably estimated. Future payments for real estate taxes and certain building operating expenses for which we are obligated are not included in operating lease costs.

XML

Inventories (Tables)

3 Months Ended

Apr. 02, 2022

Inventory Disclosure [Abstract]

Schedule of Inventories

Inventories consisted of the following (in thousands):

	April 2, 2022		January 1, 2022
Raw materials	$	11,257	$	11,752
Work in progress	68		83
Finished goods	91,887		93,809
	$	103,212	$	105,644

XML

Goodwill and Intangible Assets, Net (Tables)

3 Months Ended

Apr. 02, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Annual Amortization of Definite-Lived Tangible Assets

Annual amortization for definite-lived intangible assets for subsequent years are as follows (in thousands):

2022 (excluding the three months ended April 2, 2022)	$	1,802
2023	1,431
2024	222
2025	226
2026	222
2027	222
Thereafter	300
Total future amortization for definite-lived intangible assets	$	4,425

XML

Credit Agreement (Tables)

3 Months Ended

Apr. 02, 2022

Debt Disclosure [Abstract]

Schedule of Borrowings Under Credit Facility

The following table summarizes our borrowings under the credit facility ($ in thousands):

	April 2, 2022			January 1, 2022
Outstanding borrowings	$	413,200		$	382,500
Outstanding letters of credit	$	5,947		$	3,997
Additional borrowing capacity	$	405,853		$	438,503
Weighted-average interest rate	2.2		%	1.6		%

XML

Leases (Tables)

3 Months Ended

Apr. 02, 2022

Leases [Abstract]

Schedule of Operating Lease Costs

Lease costs were as follows (in thousands):

	Three Months Ended
	April 2, 2022		April 3, 2021
Operating lease costs(1)	$	27,078	$	23,638
Variable lease costs	$	330	$	515

___________________________

(1)Includes short-term lease costs which are not significant.

Schedule of Maturities of Operating Lease Liabilities

The maturities of operating lease liabilities as of April 2, 2022, were as follows(1) (in thousands):

2022 (excluding the three months ended April 2, 2022)	$	72,962
2023	89,790
2024	77,978
2025	68,001
2026	56,694
2027	41,517
Thereafter	86,958
Total operating lease payments(2)	493,900
Less: Interest	81,326
Present value of operating lease liabilities	$	412,574

___________________________

(1)Total operating lease payments exclude $102 million of legally binding minimum lease payments for leases signed but not yet commenced.

(2)Includes the current portion of $74 million for operating lease liabilities.

Schedule of Other Information Related Operating Leases

Other information related to operating leases was as follows:

	April 2, 2022		January 1, 2022
Weighted-average remaining lease term (years)	6.3		6.4
Weighted-average discount rate	6.0	%	6.1	%

	Three Months Ended
(in thousands)	April 2, 2022		April 3, 2021
Cash paid for amounts included in present value of operating lease liabilities	$	24,209	$	21,386
Right-of-use assets obtained in exchange for operating lease liabilities	$	17,564	$	29,454

XML

Repurchases of Common Stock (Tables)

3 Months Ended

Apr. 02, 2022

Repurchases Of Common Stock [Abstract]

Schedule of Repurchases of Common Stock

Repurchases of our common stock were as follows (in thousands):

	Three Months Ended
	April 2, 2022		April 3, 2021
Amount repurchased under Board-approved share repurchase program	$	42,308	$	167,418
Amount repurchased in connection with the vesting of employee restricted stock grants	8,690		16,764
Total amount repurchased (based on trade dates)	$	50,998	$	184,182

XML

Revenue Recognition (Tables)

3 Months Ended

Apr. 02, 2022

Revenue from Contract with Customer [Abstract]

Schedule of Deferred Contract Liabilities and Deferred Contract Assets

Deferred contract assets and deferred contract liabilities are included in our condensed consolidated balance sheets as follows (in thousands):

	April 2, 2022		January 1, 2022
Deferred contract assets included in:
Other current assets	$	26,926	$	28,048
Other non-current assets	53,244		49,343
	$	80,170	$	77,391

	April 2, 2022		January 1, 2022
Deferred contract liabilities included in:
Other current liabilities	$	34,999	$	36,490
Other non-current liabilities	68,657		63,680
	$	103,656	$	100,170

Disaggregation of Revenue

Net sales were as follows (in thousands):

	Three Months Ended
	April 2, 2022		April 3, 2021
Retail stores	$	444,336	$	489,188
Online, phone, chat and other	82,794		79,068
Total Company	$	527,130	$	568,256

Schedule of Sales Return Liability

The activity in the sales returns liability account was as follows (in thousands):

	Three Months Ended
	April 2, 2022		April 3, 2021
Balance at beginning of year	$	22,368	$	24,765
Additions that reduce net sales	26,667		23,711
Deductions from reserves	(28,758)		(23,866)
Balance at end of period	$	20,277	$	24,610

XML

Stock-based Compensation Expense (Tables)

3 Months Ended

Apr. 02, 2022

Share-based Payment Arrangement [Abstract]

Schedule of Stock-Based Compensation Expense

Total stock-based compensation expense was as follows (in thousands):

	Three Months Ended
	April 2, 2022		April 3, 2021
Stock awards	$	3,274	$	5,808
Stock options	859		608
Total stock-based compensation expense (1)	4,133		6,416
Income tax benefit	1,033		1,598
Total stock-based compensation expense, net of tax	$	3,100	$	4,818

___________________________

(1) Changes in stock-based compensation expense reflect the cumulative impact of the change in the expected achievements of certain performance targets.

XML

Net Income per Common Share (Tables)

3 Months Ended

Apr. 02, 2022

Earnings Per Share [Abstract]

Components of Basic and Diluted Net (Loss) Income per Share

The components of basic and diluted net income per share were as follows (in thousands, except per share amounts):

	Three Months Ended
	April 2, 2022		April 3, 2021
Net income	$	2,074	$	66,634
Reconciliation of weighted-average shares outstanding:
Basic weighted-average shares outstanding	22,760		25,377
Dilutive effect of stock-based awards	831		1,167
Diluted weighted-average shares outstanding	23,591		26,544
Net income per share – basic	$	0.09	$	2.63
Net income per share – diluted	$	0.09	$	2.51

XML

Commitments and Contingencies (Tables)

3 Months Ended

Apr. 02, 2022

Commitments and Contingencies Disclosure [Abstract]

Warranty Liabilities

The activity in the accrued warranty liabilities account was as follows (in thousands):

	Three Months Ended
	April 2, 2022		April 3, 2021
Balance at beginning of year	$	10,069	$	12,152
Additions charged to costs and expenses for current-year sales	4,447		4,330
Deductions from reserves	(4,750)		(4,717)
Changes in liability for pre-existing warranties during the current year, including expirations	(31)		(156)
Balance at end of period	$	9,735	$	11,609

XML

Fair Value Measurements (Details) - Level 1 - USD ($) $ in Millions	Apr. 02, 2022	Jan. 01, 2022
Other non-current assets | Available-for-sale securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities assets funding the deferred compensation plan	$ 18	$ 19
Other non-current liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation plan liability	$ 18	$ 19

XML

Inventories (Details) - USD ($) $ in Thousands	Apr. 02, 2022	Jan. 01, 2022
Inventory Disclosure [Abstract]
Raw materials	$ 11,257	$ 11,752
Work in progress	68	83
Finished goods	91,887	93,809
Inventories	$ 103,212	$ 105,644

XML

Goodwill and Intangible Assets, Net - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 02, 2022	Apr. 03, 2021	Jan. 01, 2022
Goodwill And Intangible Assets [Line Items]
Goodwill	$ 64,000		$ 64,000
Developed Technologies
Goodwill And Intangible Assets [Line Items]
Gross carrying amount	19,000		19,000
Accumulated amortization	16,000		16,000
Amortization expense	500	$ 500
Patents
Goodwill And Intangible Assets [Line Items]
Gross carrying amount	2,000		2,000
Accumulated amortization	400		300
Amortization expense	55	$ 55
Trade Names
Goodwill And Intangible Assets [Line Items]
Indefinite-lived trade name/trademarks	$ 1,400		$ 1,400

XML

Goodwill and Intangible Assets, Net - Annual Amortization for Definite-Lived Intangible (Details) $ in Thousands	Apr. 02, 2022 USD ($)
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2022 (excluding the three months ended April 2, 2022)	$ 1,802
2023	1,431
2024	222
2025	226
2026	222
2027	222
Thereafter	300
Total future amortization for definite-lived intangible assets	$ 4,425

XML

Credit Agreement - Additional Information (Details) $ in Millions	Apr. 02, 2022 USD ($)
Debt Disclosure [Abstract]
Current borrowing capacity	$ 825
Total commitment amount	$ 1,200
Maximum leverage ratio	450.00%
Minimum interest coverage ratio	300.00%

XML

Credit Agreement - Schedule of Borrowings Under Credit Facility (Details) - USD ($) $ in Thousands	Apr. 02, 2022	Jan. 01, 2022
Debt Disclosure [Abstract]
Outstanding borrowings	$ 413,200	$ 382,500
Outstanding letters of credit	5,947	3,997
Additional borrowing capacity	$ 405,853	$ 438,503
Weighted-average interest rate	2.20%	1.60%

XML

Leases - Additional Information (Details)	Apr. 02, 2022
Minimum | Retail Store Leases
Lessee, Lease, Description [Line Items]
Lease term	5 years
Minimum | Lease Vehicles and Certain Equipment Under Operating Leases
Lessee, Lease, Description [Line Items]
Lease term	3 years
Maximum | Retail Store Leases
Lessee, Lease, Description [Line Items]
Lease term	10 years
Maximum | Office and Manufacturing Leases
Lessee, Lease, Description [Line Items]
Lease term	15 years
Maximum | Lease Vehicles and Certain Equipment Under Operating Leases
Lessee, Lease, Description [Line Items]
Lease term	5 years

XML

Leases - Schedule of Operating Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 02, 2022	Apr. 03, 2021
Leases [Abstract]
Operating lease costs	$ 27,078	$ 23,638
Variable lease costs	$ 330	$ 515

XML

Leases - Schedule of Maturities of Operating Lease Liabilities (Details) - USD ($) $ in Thousands	Apr. 02, 2022	Jan. 01, 2022
Leases [Abstract]
2022 (excluding the three months ended April 2, 2022)	$ 72,962
2023	89,790
2024	77,978
2025	68,001
2026	56,694
2027	41,517
Thereafter	86,958
Total operating lease payments	493,900
Less: Interest	81,326
Present value of operating lease liabilities	412,574
Amount leases executed, not yet commenced, excluded from table.	102,000
Operating lease liabilities, current	$ 74,046	$ 72,360

XML

Leases - Schedule of Other Information Related Operating Leases (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 02, 2022	Apr. 03, 2021	Jan. 01, 2022
Leases [Abstract]
Weighted-average remaining lease term (years)	6 years 3 months 18 days		6 years 4 months 24 days
Weighted-average discount rate	6.00%		6.10%
Cash paid for amounts included in present value of operating lease liabilities	$ 24,209	$ 21,386
Right-of-use assets obtained in exchange for operating lease liabilities	$ 17,564	$ 29,454

XML

Repurchases of Common Stock - Schedule of Repurchase of Common Stock (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 02, 2022	Apr. 03, 2021
Repurchases Of Common Stock [Abstract]
Amount repurchased under Board-approved share repurchase program	$ 42,308	$ 167,418
Amount repurchased in connection with the vesting of employee restricted stock grants	8,690	16,764
Total amount repurchased (based on trade dates)	$ 50,998	$ 184,182

XML

Repurchases of Common Stock - Additional Information (Details) $ in Millions	Apr. 02, 2022 USD ($)
Repurchases Of Common Stock [Abstract]
Authorized share repurchase program	$ 600
Remaining authorized stock purchase plan	$ 361

XML

Revenue Recognition - Schedule of Deferred Contract Assets and Deferred Contract Liabilities (Details) - USD ($) $ in Thousands	Apr. 02, 2022	Jan. 01, 2022
Deferred contract assets included in:
Deferred contract assets	$ 80,170	$ 77,391
Deferred contract liabilities included in:
Deferred contract liabilities	103,656	100,170
Other current assets
Deferred contract assets included in:
Other current assets	26,926	28,048
Other non-current assets
Deferred contract assets included in:
Other non-current assets	53,244	49,343
Other current liabilities
Deferred contract liabilities included in:
Other current liabilities	34,999	36,490
Other non-current liabilities
Deferred contract liabilities included in:
Other non-current liabilities	$ 68,657	$ 63,680

XML

Revenue Recognition - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 02, 2022	Apr. 03, 2021
Disaggregation of Revenue [Line Items]
Revenue recognized, included in beginning deferred contract liability balance	$ 9	$ 7
Transferred at Point in Time | Revenue from Contract with Customer Benchmark | Timing of Transfer of Goods or Services Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue recognized at a point in time	98.00%	99.00%
SleepIQ Technology | Minimum
Disaggregation of Revenue [Line Items]
Estimated product life	4 years 6 months
SleepIQ Technology | Maximum
Disaggregation of Revenue [Line Items]
Estimated product life	5 years

XML

Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 02, 2022	Apr. 03, 2021
Disaggregation of Revenue [Line Items]
Net sales	$ 527,130	$ 568,256
Retail stores
Disaggregation of Revenue [Line Items]
Net sales	444,336	489,188
Online, phone, chat and other
Disaggregation of Revenue [Line Items]
Net sales	$ 82,794	$ 79,068

XML

Revenue Recognition - Schedule of Sales Return Liability (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 02, 2022	Apr. 03, 2021
Sales Return Liability [Roll Forward]
Balance at beginning of year	$ 22,368	$ 24,765
Additions that reduce net sales	26,667	23,711
Deductions from reserves	(28,758)	(23,866)
Balance at end of period	$ 20,277	$ 24,610

XML

Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 02, 2022	Apr. 03, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock based compensation expense	$ 4,133	$ 6,416
Income tax benefit	1,033	1,598
Total stock-based compensation expense, net of tax	3,100	4,818
Stock awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock based compensation expense	3,274	5,808
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock based compensation expense	$ 859	$ 608

XML

Profit Sharing and 401(k) Plan (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 02, 2022	Apr. 03, 2021
Profit Sharing And 401 (k) Plan [Abstract]
Employee compensation deferral (as a percent)	50.00%
Employer contributions	$ 2.8	$ 1.9

XML

Net Income per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Apr. 02, 2022	Apr. 03, 2021
Earnings Per Share [Abstract]
Net income	$ 2,074	$ 66,634
Reconciliation of weighted-average shares outstanding:
Basic weighted-average shares outstanding (in shares)	22,760,000	25,377,000
Dilutive effect of stock-based awards (in shares)	831,000	1,167,000
Diluted weighted-average shares outstanding (in shares)	23,591,000	26,544,000
Net income per share – basic (in dollars per share)	$ 0.09	$ 2.63
Net income per share – diluted (in dollars per share)	$ 0.09	$ 2.51

XML

Commitments and Contingencies (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 02, 2022	Apr. 03, 2021
Warranty Liabilities [Roll Forward]
Balance at beginning of year	$ 10,069	$ 12,152
Additions charged to costs and expenses for current-year sales	4,447	4,330
Deductions from reserves	(4,750)	(4,717)
Changes in liability for pre-existing warranties during the current year, including expirations	(31)	(156)
Balance at end of period	$ 9,735	$ 11,609